These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2857211)

  • 21. Des-gamma-carboxyprothrombin (PIVKA II) and plasma vitamin K1 in newborns and their mothers.
    von Kries R; Shearer MJ; Widdershoven J; Motohara K; Umbach G; Göbel U
    Thromb Haemost; 1992 Oct; 68(4):383-7. PubMed ID: 1448768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative changes in PIVKA-II.
    Dauti F; Hjaltalin Jonsson M; Hillarp A; Bentzer P; Schött U
    Scand J Clin Lab Invest; 2015 Nov; 75(7):562-7. PubMed ID: 26198297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of subclinical vitamin K deficiency based on PIVKA-II levels: oral versus intramuscular route.
    Bakhshi S; Deorari AK; Roy S; Paul VK; Singh M
    Indian Pediatr; 1996 Dec; 33(12):1040-3. PubMed ID: 9141807
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.
    Nakagawa T; Seki T; Shiro T; Wakabayashi M; Imamura M; Itoh T; Tamai T; Nishimura A; Yamashiki N; Matsuzaki K; Sakaida N; Inoue K; Okamura A
    Int J Oncol; 1999 Feb; 14(2):281-6. PubMed ID: 9917503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of vitamin K status of the newborn infant.
    von Kries R; Greer FR; Suttie JW
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):231-8. PubMed ID: 8492247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate.
    Bovill EG; Soll RF; Lynch M; Bhushan F; Landesman M; Freije M; Church W; McAuliffe T; Davidson K; Sadowski J
    Blood; 1993 Jan; 81(1):77-83. PubMed ID: 8417804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
    Strople J; Lovell G; Heubi J
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients.
    Umeki S; Umeki Y
    Med Lab Sci; 1990 Apr; 47(2):103-7. PubMed ID: 2381266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin K status of premature infants: implications for current recommendations.
    Kumar D; Greer FR; Super DM; Suttie JW; Moore JJ
    Pediatrics; 2001 Nov; 108(5):1117-22. PubMed ID: 11694690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
    Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
    Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteins invoked by vitamin K absence and clotting times in clinically ill cats.
    Center SA; Warner K; Corbett J; Randolph JF; Erb HN
    J Vet Intern Med; 2000; 14(3):292-7. PubMed ID: 10830543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of PIVKA-II as a marker of hepatocellular carcinoma].
    Arima K; Kodama T; Suga M; Sakamoto H; Ohe Y; Yachi A
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3049-52. PubMed ID: 2476968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PIVKA-II concentrations in patients with cystic fibrosis.
    Cornelissen EA; van Lieburg AF; van Oostrom CG; Monnens L
    J Clin Pathol; 1992 Aug; 45(8):742. PubMed ID: 1401195
    [No Abstract]   [Full Text] [Related]  

  • 34. Des-gamma-carboxyprothrombin (PIVKA-II) levels in maternal serum throughout gestation.
    Nishiguchi T; Matsuyama K; Kobayashi T; Kanayama N
    Semin Thromb Hemost; 2005 Jun; 31(3):351-5. PubMed ID: 16052408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The predictability of bleeding by prothrombin times sensitive or insensitive to PIVKA during intensive oral anticoagulation.
    Arnesen H; Smith P
    Thromb Res; 1991 Feb; 61(3):311-4. PubMed ID: 1822957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How does the Pivka inhibitor interfere with the one-stage prothrombin time?
    Talstad I
    Haemostasis; 1985; 15(5):304-9. PubMed ID: 4076836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PIVKA (protein induced by vitamin K absence or antagonists)].
    Shirahata A; Shiiki M; Enomoto M
    Rinsho Byori; 1987 Apr; Spec No 70():108-17. PubMed ID: 3302381
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns.
    Motohara K; Endo F; Matsuda I
    Lancet; 1985 Aug; 2(8449):242-4. PubMed ID: 2862419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.
    Caviglia GP; Ribaldone DG; Abate ML; Ciancio A; Pellicano R; Smedile A; Saracco GM
    Scand J Gastroenterol; 2018 Jun; 53(6):734-740. PubMed ID: 29667463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
    Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
    Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.